5 insiders reported 72 Form 4 transactions for BioXcel Therapeutics, Inc. (BTAI) over the past 18 months (most recent 2026-06-17). Recent activity: Yocca Frank (Chief Scientific Officer) Buy 35 shares, Steinhart Richard I (Chief Financial Officer) Buy 35 shares, Mehta Vimal (CEO and President) Buy 219 shares, Rodriguez Javier (See Remarks) Buy 35 shares, Steinhart Richard I (Chief Financial Officer) Buy 17,500 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-17 | Yocca Frank | Chief Scientific Officer | Buy | 35 | $0 |
| 2026-06-17 | Steinhart Richard I | Chief Financial Officer | Buy | 35 | $0 |
| 2026-06-17 | Mehta Vimal | CEO and President | Buy | 219 | $0 |
| 2026-06-17 | Rodriguez Javier | See Remarks | Buy | 35 | $0 |
| 2026-05-22 | Steinhart Richard I | Chief Financial Officer | Buy | 17,500 | $0 |
| 2026-05-22 | Yocca Frank | Chief Scientific Officer | Buy | 17,500 | $0 |
| 2026-05-22 | Mehta Vimal | CEO and President | Buy | 49,758 | $0 |
| 2026-05-22 | Rodriguez Javier | See Remarks | Buy | 17,500 | $0 |
| 2026-05-22 | Steinhart Richard I | Chief Financial Officer | Sell | 6,845 | $7,427 |
| 2026-05-22 | Yocca Frank | Chief Scientific Officer | Sell | 6,845 | $7,427 |
| 2026-05-22 | Mehta Vimal | CEO and President | Sell | 19,419 | $21,108 |
| 2026-05-22 | Rodriguez Javier | See Remarks | Sell | 6,560 | $7,111 |
| 2026-05-07 | Steinhart Richard I | Chief Financial Officer | Buy | 9,000 | $0 |
| 2026-05-07 | Yocca Frank | Chief Scientific Officer | Buy | 9,000 | $0 |
| 2026-05-07 | Mehta Vimal | CEO and President | Buy | 18,000 | $0 |
| 2026-05-07 | Rodriguez Javier | See Remarks | Buy | 9,000 | $0 |
| 2026-03-16 | Steinhart Richard I | Chief Financial Officer | Buy | 33 | $0 |
| 2026-03-16 | Steinhart Richard I | Chief Financial Officer | Buy | 35 | $0 |
| 2026-03-16 | Yocca Frank | Chief Scientific Officer | Buy | 33 | $0 |
| 2026-03-16 | Yocca Frank | Chief Scientific Officer | Buy | 35 | $0 |
| 2026-03-16 | Mehta Vimal | CEO and President | Buy | 164 | $0 |
| 2026-03-16 | Mehta Vimal | CEO and President | Buy | 219 | $0 |
| 2026-03-16 | Rodriguez Javier | See Remarks | Buy | 33 | $0 |
| 2026-03-16 | Rodriguez Javier | See Remarks | Buy | 35 | $0 |
| 2025-12-15 | Steinhart Richard I | Chief Financial Officer | Buy | 33 | $0 |
Source: SEC Form 4 filings · as of 2026-06-17